World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
66
Citations
19075
World Ranking
8537
National Ranking
3839

Overview

Matthew D. Hall is affiliated with the National Institutes of Health in the United States. Their research spans across multiple fields, primarily focusing on Medicine and Biochemistry, Genetics and Molecular Biology. Within these main fields, they have contributed significantly to subfields including Molecular Biology, Infectious Diseases, Oncology, Pulmonary and Respiratory Medicine, and Computational Theory and Mathematics.

The scientist's work addresses various topics relevant to current biomedical challenges. These include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Computational Drug Discovery Methods
  • Glioma Diagnosis and Treatment
  • Bacteriophages and microbial interactions
  • Cancer, Hypoxia, and Metabolism
  • Polyomavirus and related diseases

Matthew D. Hall has published frequently in several scientific venues, with the highest number of publications appearing in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • ACS Pharmacology & Translational Science
  • Journal of Medicinal Chemistry
  • Radiotherapy and Oncology

Collaboration is a notable aspect of their career. Frequent coauthors include:

  • Min Shen (59 publications)
  • Anton Simeonov (30 publications)
  • Samarjit Patnaik (22 publications)
  • Carleen Klumpp-Thomas (20 publications)
  • Xin Hu (20 publications)

The following are some recent publications authored by or involving Matthew D. Hall:

  • Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19, 2020, ACS Central Science
  • The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1, 2023, Redox Biology
  • Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses, 2021, Journal of Clinical Immunology
  • Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling, 2021, Nature Communications
  • Accelerating antiviral drug discovery: lessons from COVID-19, 2023, Nature Reviews Drug Discovery

Best Publications

  • Revisiting the role of ABC transporters in multidrug-resistant cancer

    Robert W. Robey;Kristen M. Pluchino;Matthew D. Hall;Antonio T. Fojo;Antonio T. Fojo

  • Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes

    Ding-Wu Shen;Lynn M. Pouliot;Matthew D. Hall;Michael M. Gottesman

  • Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

    Richard T. Eastman;Jacob S. Roth;Jacob S. Roth;Kyle R. Brimacombe;Anton Simeonov

  • An Abundance of Rare Functional Variants in 202 Drug Target Genes Sequenced in 14,002 People

    Matthew R. Nelson;Daniel Wegmann;Margaret G. Ehm;Darren Kessner

  • Platinum(IV) antitumour compounds: their bioinorganic chemistry

    Matthew D. Hall;Trevor W. Hambley

  • The Discovery and Development of Cisplatin

    Rebecca A. Alderden;Matthew D. Hall;Trevor W. Hambley

  • The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy*

    Matthew D. Hall;Mitsunori Okabe;Ding-Wu Shen;Xing-Jie Liang

  • Basis for design and development of platinum(IV) anticancer complexes.

    Matthew D Hall;Howard R Mellor;Richard Callaghan;Trevor W Hambley

  • Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin and Other Platinum Complexes

    Matthew D. Hall;Katherine A. Telma;Ki-Eun Chang;Tobie D. Lee

  • Collateral sensitivity as a strategy against cancer multidrug resistance.

    Kristen M. Pluchino;Matthew D. Hall;Andrew S. Goldsborough;Richard Callaghan

  • Toward a Better Understanding of the Complexity of Cancer Drug Resistance

    Michael M. Gottesman;Orit Lavi;Matthew D. Hall;Jean Pierre Gillet

  • Cisplatin is retained in the cochlea indefinitely following chemotherapy.

    Andrew M. Breglio;Andrew M. Breglio;Andrew M. Breglio;Aaron E. Rusheen;Aaron E. Rusheen;Eric D. Shide;Katharine A. Fernandez

  • Is Resistance Useless? Multidrug Resistance and Collateral Sensitivity

    Matthew D. Hall;Misty D. Handley;Michael M. Gottesman

  • Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells

    Hemant Sarin;Ariel S Kanevsky;Haitao Wu;Kyle R Brimacombe

  • Assay Guidance Manual [Internet]

    Sarine Markossian;Abigail Grossman;Kyle Brimacombe;Michelle Arkin

  • Bioreductive activation and drug chaperoning in cobalt pharmaceuticals

    Matthew D. Hall;Matthew D. Hall;Timothy W. Failes;Natsuho Yamamoto;Trevor W. Hambley

  • Imaging the Function of P-Glycoprotein With Radiotracers: Pharmacokinetics and In Vivo Applications

    P Kannan;P Kannan;C John;S S Zoghbi;C Halldin

  • Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance

    Gergely Szakács;Matthew D. Hall;Michael M. Gottesman;Ahcène Boumendjel

  • Synthesis, Activity, and Pharmacophore Development for Isatin-β-thiosemicarbazones with Selective Activity toward Multidrug-Resistant Cells

    Matthew D. Hall;Noeris K. Salam;Jennifer L. Hellawell;Henry M. Fales

  • Manganese Transport and Trafficking: Lessons Learned from Saccharomyces cerevisiae

    Valeria Cizewski Culotta;Mei Yang;Matthew D. Hall

Frequent Co-Authors

Anton Simeonov
Anton Simeonov National Institutes of Health
Michael M. Gottesman
Michael M. Gottesman National Institutes of Health
Min Shen
Min Shen National Institutes of Health
Trevor W. Hambley
Trevor W. Hambley University of Sydney
Ajit Jadhav
Ajit Jadhav Pfizer (Germany)
Rajarshi Guha
Rajarshi Guha Google (United States)
Wei Zheng
Wei Zheng National Institutes of Health
Suresh V. Ambudkar
Suresh V. Ambudkar National Institutes of Health
Robert B. Innis
Robert B. Innis National Institutes of Health
Richard Callaghan
Richard Callaghan Australian National University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Biology and Biochemistry, there is a wealth of related career opportunities that can be accessed through online education. Many universities now offer flexible programs designed to accommodate working professionals and distance learners.

If you are interested in the business and administration side of healthcare, a phd in healthcare management online can lead to leadership roles in hospitals, insurance, or health systems.

Aspiring pharmacists can pursue a pharm d online programs to gain advanced knowledge and credentials for clinical pharmacy positions.

There are also options for those fascinated by human movement and exercise science. Students can consider fitness degrees online or explore the best online kinesiology degree programs to prepare for roles in rehabilitation, sports science, or personal training.

These online pathways make it easier than ever to specialize your biology or biochemistry background and pursue a rewarding career in health, wellness, or scientific research.

Best Scientists Citing Matthew D. Hall

Trending Scientists

Recently Published Articles